Audited Financial Results (Standalone and Consolidated) for the year ended 31st March 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Relic Technologies Ltd reported audited annual results for FY2026 with an unmodified (clean) audit opinion from D. Kothary & Co. Standalone total assets doubled from Rs 1,002.85 lakhs to Rs 2,046.59 lakhs year-over-year, while cash and cash equivalents surged from Rs 0.95 lakhs to Rs 764.04 lakhs. Trade receivables grew significantly from Rs 202.97 lakhs to Rs 1,233.25 lakhs, though this large receivable position warrants monitoring. On a consolidated basis, the company includes two subsidiaries (Relic Pharma Limited and Truhealthy Wellness Private Limited), which collectively reported a net loss of Rs 748.69 lakhs for the year, indicating headwinds from subsidiary operations. Pre-tax profit on standalone basis stood at Rs 1,070.30 lakhs. The auditors confirmed no material uncertainties regarding the company's ability to continue as a going concern.
The clean audit opinion and strong standalone asset growth are positive signals, though investors should note the substantial consolidated losses from subsidiaries and the high trade receivables balance which could indicate aggressive revenue recognition or customer payment delays.